Uganda: Breakthrough Cancer Treatment - Vmat, Imrt Revolutionalise Patient Care
[Nile Post] In the ever-evolving landscape of cancer treatment, two innovative therapies are making waves: Volumetric Modulated Arc Therapy (VMAT) and Intensity-Modulated Radiation Therapy (IMRT). These cutting-edge approaches are transforming the way physicians target and treat cancer, offering new hope to patients worldwide. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 17, 2024 Category: African Health Tags: East Africa Health and Medicine Uganda Source Type: news

RaySearch's RayCare 2024A interoperable with Varian TrueBeam
Radiation therapy clinic software provider RaySearch Laboratories' RayCare 2024A oncology information system has been certified interoperable with Varian TrueBeam linear accelerators, version 3.0. In May 2023, the company's RayCare 5B was certified interoperable with TrueBeam 3.0, 17 months after its release. In contrast, this new interoperability certificate for 2024A comes before its release, which is scheduled for June 2024. TrueBeam is Varian's treatment delivery platform that supports all treatment techniques and capabilities that are provided by C-arm linacs, including intensity-modulated radiation therapy (IMRT), ...
Source: Headlines - May 16, 2024 Category: Radiology Authors: staff writers Tags: Industry News Source Type: news

Intensity-Modulated Radiation Therapy Best for Locally Advanced NSCLC
FRIDAY, Sept. 15, 2023 -- Intensity-modulated radiation therapy (IMRT) shows benefits over 3D-conformal (3D-CRT) radiotherapy for patients with locally advanced non-small cell lung cancer (NSCLC), according to a study presented at the International... (Source: - Pharma News)
Source: - Pharma News - September 15, 2023 Category: Pharmaceuticals Source Type: news

IMRT Best for Locally Advanced NSCLC, Study Suggests
(MedPage Today) -- SINGAPORE -- Intensity-modulated radiation therapy (IMRT) should be the radiation technique of choice for unresectable locally advanced non-small lung cancer (NSCLC), a secondary analysis of a randomized trial suggested. In... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 13, 2023 Category: Hematology Source Type: news

Long-term Outcomes of Radiation Techniques for Locally Advanced Non-Small Cell Lung Cancer Presented at IASLC 2023 Conference in Singapore
Intensity-modulated radiation therapy, or IMRT, should be utilized for locally advanced NSCLC to reduce the risk of severe pulmonary toxicity and radiation exposure to the heart, according to research presented today at the International Association for the Study of Lung Cancer 2023 World... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 12, 2023 Category: Pharmaceuticals Tags: SVY TRI TDS Source Type: news

IMRT Dosing Strategy Eases Dysphagia in Head and Neck Cancer
(MedPage Today) -- In patients with head and neck cancer, a strategy to reduce the radiation dose to dysphagia-and aspiration-related structures improved swallowing and other functional outcomes compared with standard intensity-modulated radiotherapy... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 8, 2023 Category: Hematology Source Type: news

Adaptive RT Fails to Relieve Dry Mouth in Head and Neck Cancer
(MedPage Today) -- Use of weekly adaptive radiotherapy (RT) failed to decrease xerostomia (dry mouth) in oropharyngeal cancer patients when compared with standard intensity-modulated RT (IMRT), the phase III ARTIX trial found. Of the 131 patients... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 1, 2023 Category: Hematology Source Type: news

CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer
(MedPage Today) -- TAMPA, Fla. -- More than 70% of patients with unresectable, locally advanced vulvar carcinoma had complete responses to chemoradiation with intensity-modulated radiation therapy (IMRT), according to a prospective study reported... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 27, 2023 Category: Hematology Source Type: news

Improved OS With Hyperfractionated RT in Recurrent Nasopharyngeal Carcinoma
(MedPage Today) -- Compared with standard fractionation, hyperfractionated intensity-modulated radiotherapy (IMRT) could significantly increase overall survival (OS), as well as reduce the rate of severe late complications in patients with locally... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 21, 2023 Category: Hematology Source Type: news

Toronto Cancer Center Hosts SMARTEST Mesothelioma Clinical Trial
Princess Margaret Cancer Centre in Toronto recently opened a first-of-its-kind clinical trial that hopes to build on earlier pioneering efforts to turn pleural mesothelioma into a more manageable, potentially survivable disease. Expectations are high. This single-center phase II clinical trial is named SMARTEST, and follows in the wake of earlier mesothelioma trials SMART and SMARTER in Toronto. SMARTEST is an acronym for Surgery for Mesothelioma After Radiation Therapy using Exquisite Systemic Therapy. “The hope is that we find an effective therapy with little toxicity. That’s the dream for every cancer doctor,...
Source: Asbestos and Mesothelioma News - June 28, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Source Type: news

Duke Study Suggests Radiation Does Not Extend Mesothelioma Survival
A dual registry analysis by the esteemed Duke University Medical Center has concluded that adjuvant hemithoracic radiation does not improve survival when combined with aggressive surgery for patients with malignant pleural mesothelioma. Although the U.S. National Comprehensive Cancer Network and the European Society for Medical Oncology recommend the adjuvant radiation – as do many specialists – the Duke research team has challenged the conventional treatment with this report. “The receipt of adjuvant hemithoracic radiation was not associated with improved survival when compared to no radiation,” the authors ...
Source: Asbestos and Mesothelioma News - August 9, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Memorial Sloan Kettering Opening New Mesothelioma Clinical Trial
Memorial Sloan Kettering Cancer Center in New York City will begin recruiting soon for its latest clinical trial involving patients with malignant pleural mesothelioma and the expanded use of immunotherapy. The single-center, phase I study will explore the effectiveness of pembrolizumab in combination with intensity-modulated pleural radiation therapy, known as IMPRINT, in treating unresectable disease. Pembrolizumab, also known by the brand name Keytruda, was approved by the U.S. Food and Drug Administration in 2020 for treatment of a small subset of mesothelioma patients. As a well-known immunotherapy drug, pemb...
Source: Asbestos and Mesothelioma News - May 26, 2021 Category: Environmental Health Authors: Matt Bardsley Source Type: news

MRI profiles genomic characteristics of glioblastoma
Using MRI, a team of more than 40 investigators has created a profile of th...Read more on AuntMinnie.comRelated Reading: AI can identify sarcopenia in glioblastoma patients Photon IMRT falls short in glioblastoma study SNMMI 2020: PET tracer could image, treat glioblastoma MRI, blood tests could guide care for glioblastoma AI algorithm predicts glioblastoma patient survival (Source: Headlines)
Source: Headlines - February 11, 2021 Category: Radiology Source Type: news

Reduced-dose RT with Cisplatin improves outcomes for HPV-associated oropharyngeal carcinoma
(NRG Oncology) A combination of reduced-dose radiotherapy using intensity-modulated radiotherapy (IMRT) combined with concurrent cisplatin met the threshold for disease control and quality of life compared to the standard of care for good-risk patients with HPV-associated oropharyngeal squamous cell carcinoma on the NRG Oncology clinical trial NRG-HN002. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 29, 2021 Category: Cancer & Oncology Source Type: news

IMRT New Standard of Care for High-Risk Cervical Cancer IMRT New Standard of Care for High-Risk Cervical Cancer
Intensity-modulated radiotherapy was as effective as three-dimensional conformal radiotherapy but was associated with significantly less morbidity.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 2, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news